CASI Pharmaceuticals (ENM) Cash flow

0 Followers

CASI Pharmaceuticals Cash Flow

CH:ENM's free cash flow for Q2 2026 was $0.00. For the 2026 fiscal year, CH:ENM's free cash flow was decreased by $8.69M and operating cash flow was $0.00. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Mar 25	Dec 23	Mar 23	Dec 21
Operating Cash Flow	$ -20.75M	$ -29.22M	$ -19.97M	$ -21.09M	$ -26.84M
Investing Cash Flow	$ 951.00K	$ 11.24M	$ -9.67M	$ 31.16M	$ -20.69M
Financing Cash Flow	$ 11.25M	$ 15.43M	$ -907.00K	$ -3.27M	$ 29.64M
End Cash Position	$ 5.63M	$ 13.47M	$ 17.08M	$ 47.11M	$ 38.70M
Free Cash Flow	$ -20.77M	$ -29.46M	$ -22.21M	$ -26.70M	$ -42.34M

Currency in USD